Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
36.06 USD | +0.70% | -4.57% | +30.22% |
05-24 | Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing | MT |
05-21 | Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.22% | 2.75B | |
+17.13% | 124B | |
+18.81% | 112B | |
+3.52% | 22.94B | |
-11.73% | 17.02B | |
-16.50% | 16.88B | |
-39.57% | 16.87B | |
+2.91% | 13.63B | |
+22.40% | 11.61B | |
+108.76% | 10.31B |
- Stock Market
- Equities
- PTCT Stock
- News PTC Therapeutics, Inc.
- Transcript : PTC Therapeutics, Inc., Q3 2023 Earnings Call, Oct 26, 2023